Explore Stanford technologies available for licensing:

Engineers at the Cui Research group have recently patented a low-cost, high-performance solid electrolyte for solid-state lithium-ion batteries.

Stanford researchers have developed a method called KleinPAT, for creating sound models in seconds, making it cost effective to simulate sounds for many different objects in a virtual environment.

Disease indication:
Cancer: Renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), lymphoma and potentially other MYC-driven cancer

Drug format: Small molecule compounds, alone or in combination with other chemotherapeutic drugs

Disease indication
Cancer: Renal cell carcinoma (RCC), hepatocellular carcinoma (HCC)

Drug format: Small molecule compounds, alone or in combination with other chemotherapeutic drugs

Drug class: First-in-class

Stanford researchers have engineered an exceptionally bright, cyan-excitable orange-red fluorescent protein (CyOFP) that can be used both for multiplex imaging with GFP and for high-sensitivity, bioluminescent in vivo imaging.

Engineers in the Solgaard lab have developed a high-speed, random access grating light valve (GLV) for phase modulation to steer and focus light in LIDAR and 3D imaging applications.

Stanford researchers have designed a frequency-multiplexed neural probe architecture that enables massive scaling of electrophysiological recording from neurons.

Stanford researchers have developed various high ionic conductivity thin films (LiAlO₂, LiAlF₄) to stabilize lithium ion battery electrodes without sacrificing power density.

Stanford researchers have designed a non-invasive, low power ultrasonic neuromodulation device which can target tissue deep in the brain with high spatial-temporal resolution.

Stanford researchers have patented a real-time auralization-reverberation system for providing immersive and interactive audio environments.

Stanford researchers at the Vuckovic Lab have developed a dispersion engineered phased array which can be used as a beam steering device for compact LIDAR or ranging systems critical for self-driving cars, logistics, and the security sector.

We created a transgenic mouse on the FVB background in which the transgene is comprised of a strong constitutive promoter (CAG) driving expression of a dual reporter gene (luciferase and GFP). We called the original FVB mouse L2G85.

The N2N allele contains a loxP site and an HA epitope upstream of exon 4, and a Frt-flanked neomycin resistance cassette (neo), followed by a luciferase sequence, downstream of exon 5, of the nuclear factor, erythroid derived 2, like 2 (Nfe212) gene.

Stanford University and Honda Motor Co. have patented a device and method for estimating workpiece contact states during robotic manipulation tasks.

Researchers at Stanford have developed chimeric antigen receptors (CARs) that target glypican-2 (GPC2) and can be used to treat solid tumors. CAR-engineered T cells have shown great promise as cancer therapeutics.